home / stock / axgt / axgt news


AXGT News and Press, Axovant Gene Therapies Ltd. From 10/16/20

Stock Information

Company Name: Axovant Gene Therapies Ltd.
Stock Symbol: AXGT
Market: NYSE

Menu

AXGT AXGT Quote AXGT Short AXGT News AXGT Articles AXGT Message Board
Get AXGT Alerts

News, Short Squeeze, Breakout and More Instantly...

AXGT - What Are The Best Penny Stocks To Buy Right Now? 5 Names To Know

Should These Be On Your List Of Penny Stocks To Buy Now? Friday has produced some massive runners already. Whether it’s large-cap stocks like Amazon Inc. ( AMZN Stock Report ) or penny stocks like Kaixin Auto Holdings ( KXIN Stock Report ), the market is seeing a ...

AXGT - Axovant nabs Rare Pediatric Disease tag for AXO-AAV-GM2 in rare neurodegenerative disorder

The FDA has granted Rare Pediatric Disease Designation to Axovant Gene Therapies (AXGT) for AXO-AAV-GM2, a gene therapy delivered directly to the central nervous system for GM2 gangliosidosis, also known as Tay-Sachs and Sandhoff disease, which is a rare and fatal pediatric neurodegenerative ...

AXGT - Axovant Gene Therapies Receives Rare Pediatric Disease Designation for AXO-AAV-GM2 for Tay-Sachs and Sandhoff Disease

NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies for neurological diseases, today announced that it has received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration...

AXGT - Axovant Gene Therapies candidate nabs Rare Pediatric Disease tag for nerve cell disorder

The FDA grants Rare Pediatric Disease designation to Axovant Gene Therapies' (AXGT) AXO-AAV-GM1, an AAV0-based gene therapy for the GM1 gangliosidosis, a rare inherited disorder characterized by the progressive destruction of nerve cells (neurons) in the brain and spinal cord.Rare Pediatric D...

AXGT - Axovant Gene Therapies Receives Rare Pediatric Disease Designation for AXO-AAV-GM1 for GM1 Gangliosidosis

NEW YORK, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies for neurological diseases, today announced that it has received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration...

AXGT - New commercial chief at Axovant Gene Therapies

Axovant Gene Therapies (AXGT) appoints Kristiina Vuori, M.D., Ph.D., to its Board of Directors and the promotes Parag. V. Meswani, Pharm.D., from SVP, Commercial Strategy & Operations to Chief Commercial Officer ((CCO)), effective October 6, 2020. Dr. Vuori is a Professor at the Sanford B...

AXGT - Axovant Gene Therapies Strengthens Board of Directors and Announces New Chief Commercial Officer

Kristiina Vuori, M.D., Ph.D. is a leading genetics and cancer researcher who serves as President and Board member of Sanford Burnham Prebys Medical Discovery Institute A ppointment of Dr. Vuori establishes a majority independent Board of Directors...

AXGT - DDD, OCUL, AYTU and CLSK among midday movers

Gainers: The Peck Company (PECK) +67%.CVD Equipment (CVV) +56%.Sunworks (SUNW) +47%.Ocean Power Technologies (OPTT) +42%.ReneSola (SOL) +35%.Taiwan Liposome (TLC) +29%.Ocular Therapeutix (OCUL) +20%.Broadwind (BWEN) +19%.Chimerix (CMRX) +16%.3D Systems (DDD) +16%.Losers: Electro-Sen...

AXGT - Ocular Therapeutix and American Well among healthcare gainers, ARCA biopharma and Axovant Gene Therapies among losers

Gainers: Taiwan Liposome (TLC) +36%. Ocular Therapeutix (OCUL) +21%. LogicBio Therapeutics (LOGC) +11%. American Well (AMWL) +11%. Tiziana Life Sciences (TLSA) +11%.Losers: Enlivex Therapeutics (ENLV) -12%. Aytu BioScience (AYTU) -12%. Xtant Medical (XTNT) -11%. ARCA bioph...

AXGT - AYX, SOL, LAC and CRBP among midday movers

Gainers: Pioneer Power Solutions (PPSI) +323%.Ocean Power Technologies (OPTT) +82%.Electro-Sensors (ELSE) +30%.Asia Pacific Wire & Cable (APWC) +28%.Alteryx (AYX) +27%.Piedmont Lithium (PLL) +26%.ReneSola (SOL) +25%.TOMI Environmental Solutions (TOMZ) +25%TransAct Technolog...

Previous 10 Next 10